Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q1 EPS of ($0.31), $0.06 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $8 million versus the consensus estimate of $7.63 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2026 revenue of $37-41 million, versus the consensus of $39.2 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.